Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sureau

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Immunobiology|May 1, 1988
Interleukin 2 increases protection against experimental rabiesP Perrin, M L Joffret, C Leclerc, et al.
Cellular Immunology|August 1, 1987
The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2D Oth, G Mercier, P Perrin, et al.
Biologicals : Journal of the International Association of Biological Standardization|April 1, 1991
Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 productionM L Joffret, C Zanetti, S Morgeaux, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 7, 1981
[Prevention of inter-human rabies transmission after corneal graft]P Sureau, D Portnoi, P Rollin, et al.
Biochemical and Biophysical Research Communications|December 31, 1981
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cellsA G Hovanessian, P Rollin, Y Rivière, et al.
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|January 1, 1990
[Antigenic variants of rabies virus isolated in the northeast and southeast of Brazil. Preliminary study]P M Germano, E V Silva, E V Silva, et al.
Vaccine|December 1, 1986
An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure scheduleI Vodopija, P Sureau, M Lafon, et al.
Revista De Saude Publica|December 1, 1989
[The efficacy of the ERA rabies vaccine, in mice against 4 antigenic variants of rabies virus]E B Erbolato, E V da Silva, O Miguel, et al.
Presse Medicale (Paris, France : 1983)|March 28, 1987
[Serological demonstration of the presence of Hantaan virus in Rattus norvegicus rats in an urban environment in France]P E Rollin, B Seguin, F Moutou, et al.
Archives De L'Institut Pasteur De Madagascar|January 1, 1978
[Current status of arbovirus research in Madagascar]P Coulanges, P Sureau, Y Robin, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Immunobiology|May 1, 1988
Interleukin 2 increases protection against experimental rabiesP Perrin, M L Joffret, C Leclerc, et al.
Cellular Immunology|August 1, 1987
The association of the rabies glycoprotein with liposome (immunosome) induces an in vitro specific release of interleukin 2D Oth, G Mercier, P Perrin, et al.
Biologicals : Journal of the International Association of Biological Standardization|April 1, 1991
Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 productionM L Joffret, C Zanetti, S Morgeaux, et al.
Comptes Rendus Des Seances De L'Academie Des Sciences. Serie III, Sciences De La Vie|December 7, 1981
[Prevention of inter-human rabies transmission after corneal graft]P Sureau, D Portnoi, P Rollin, et al.
Biochemical and Biophysical Research Communications|December 31, 1981
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cellsA G Hovanessian, P Rollin, Y Rivière, et al.
Boletin De La Oficina Sanitaria Panamericana. Pan American Sanitary Bureau|January 1, 1990
[Antigenic variants of rabies virus isolated in the northeast and southeast of Brazil. Preliminary study]P M Germano, E V Silva, E V Silva, et al.
Vaccine|December 1, 1986
An evaluation of second generation tissue culture rabies vaccines for use in man: a four-vaccine comparative immunogenicity study using a pre-exposure vaccination schedule and an abbreviated 2-1-1 postexposure scheduleI Vodopija, P Sureau, M Lafon, et al.
Revista De Saude Publica|December 1, 1989
[The efficacy of the ERA rabies vaccine, in mice against 4 antigenic variants of rabies virus]E B Erbolato, E V da Silva, O Miguel, et al.
Presse Medicale (Paris, France : 1983)|March 28, 1987
[Serological demonstration of the presence of Hantaan virus in Rattus norvegicus rats in an urban environment in France]P E Rollin, B Seguin, F Moutou, et al.
Archives De L'Institut Pasteur De Madagascar|January 1, 1978
[Current status of arbovirus research in Madagascar]P Coulanges, P Sureau, Y Robin, et al.
Pageof 10